Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Opioids

FDA 2009

Opioid anesthetics

Fentanyl Citrate

Approved 30 Oct 2009TransmucosalTroche/lozenge

The FDA lists this product in 38 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: FENTANYL CITRATE EQ 1.2MG BASE

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

FENTANYL CITRATE EQ 0.6MG BASE · Troche/lozengeANDA077312-003 · Discontinued
FENTANYL CITRATE EQ 0.2MG BASE · Troche/lozengeANDA077312-001 · Discontinued
FENTANYL CITRATE EQ 1.6MG BASE · Troche/lozengeANDA077312-006 · Discontinued
FENTANYL CITRATE EQ 0.8MG BASE · Troche/lozengeANDA077312-004 · Discontinued
FENTANYL CITRATE EQ 0.4MG BASE · Troche/lozengeANDA077312-002 · Discontinued
FENTANYL CITRATE EQ 1.2MG BASE · Troche/lozengeThis page
FENTANYL CITRATE EQ 0.6MG BASE · Troche/lozengeANDA078907-003 · Discontinued
FENTANYL CITRATE EQ 0.2MG BASE · Troche/lozengeANDA078907-001 · Discontinued
FENTANYL CITRATE EQ 1.6MG BASE · Troche/lozengeANDA078907-006 · Discontinued
FENTANYL CITRATE EQ 0.8MG BASE · Troche/lozengeANDA078907-004 · Discontinued

More in opioids

Naloxone HydrochlorideSpray
Lofexidine HydrochlorideTablet

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

FENTANYL CITRATE EQ 0.4MG BASE · Troche/lozengeANDA078907-002 · Discontinued

FENTANYL CITRATE EQ 1.2MG BASE · Troche/lozengeANDA078907-005 · Discontinued

FENTANYL CITRATE EQ 0.05MG BASE/ML · InjectableNDA019115-001 · Prescription

FENTANYL CITRATE EQ 2.5MG BASE/50ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionNDA215870-001 · Discontinued

FENTANYL CITRATE EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionNDA215870-002 · Discontinued

FENTANYL CITRATE EQ 0.05MG BASE/ML · InjectableANDA212086-001 · Prescription

FENTANYL CITRATE EQ 0.05MG BASE/ML · InjectableANDA073488-001 · Discontinued

FENTANYL CITRATE EQ 0.6MG BASE · TabletANDA079075-004 · Discontinued

FENTANYL CITRATE EQ 0.2MG BASE · TabletANDA079075-002 · Discontinued

FENTANYL CITRATE EQ 0.8MG BASE · TabletANDA079075-005 · Discontinued

FENTANYL CITRATE EQ 0.4MG BASE · TabletANDA079075-003 · Discontinued

FENTANYL CITRATE EQ 0.1MG BASE · TabletANDA079075-001 · Discontinued

FENTANYL CITRATE EQ 0.8MG BASE · TabletANDA206329-006 · Discontinued

FENTANYL CITRATE EQ 0.4MG BASE · TabletANDA206329-004 · Discontinued

FENTANYL CITRATE EQ 0.2MG BASE · TabletANDA206329-002 · Discontinued

FENTANYL CITRATE EQ 0.6MG BASE · TabletANDA206329-005 · Discontinued

FENTANYL CITRATE EQ 0.3MG BASE · TabletANDA206329-003 · Discontinued

FENTANYL CITRATE EQ 0.1MG BASE · TabletANDA206329-001 · Discontinued

FENTANYL CITRATE EQ 0.05MG BASE/ML · InjectableANDA070636-001 · Discontinued

FENTANYL CITRATE EQ 0.05MG BASE/ML · InjectableANDA070637-001 · Discontinued

FENTANYL CITRATE EQ 0.025MG BASE/0.5ML · InjectableNDA019101-002 · Prescription

FENTANYL CITRATE EQ 0.05MG BASE/ML · InjectableNDA019101-001 · Prescription

FENTANYL CITRATE EQ 0.8MG BASE · TabletANDA207338-006 · Discontinued

FENTANYL CITRATE EQ 0.4MG BASE · TabletANDA207338-004 · Discontinued

FENTANYL CITRATE EQ 0.2MG BASE · TabletANDA207338-002 · Discontinued

FENTANYL CITRATE EQ 0.6MG BASE · TabletANDA207338-005 · Discontinued

FENTANYL CITRATE EQ 0.3MG BASE · TabletANDA207338-003 · Discontinued

FENTANYL CITRATE EQ 0.1MG BASE · TabletANDA207338-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA077312.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Fentanyl Citrate
Drug class: Opioid anesthetics, Phenylpiperidine derivatives
Group: Opioids
Route: Transmucosal
Dosage form: Troche/lozenge
Applicant: Par Pharm
Status: Discontinued
FDA approval: 30 Oct 2009
Application: ANDA077312-005
RxCUI: 142436

FDA 2023

NaltrexoneFor suspension, extended release

FDA 2023Brixadibuprenorphine · Solution, extended release

FDA 2023Acetaminophen and Ibuprofenacetaminophen · Tablet

FDA 2021Kloxxadonaloxone hydrochloride · Spray

FDA 2019AlvimopanCapsule

FDA 2018BuprenorphineFilm, extended release

FDA 2018Buprenorphine Hydrochloride and Naloxone Hydrochloridebuprenorphine hydrochloride · Film

FDA 2018Lucemyralofexidine hydrochloride · Tablet

FDA 2018Remifentanil HydrochlorideInjectable

FDA 2017Ibuprofen and Pseudoephedrine Hydrochlorideibuprofen · Capsule

FDA 2017Sublocadebuprenorphine · Solution, extended release

FDA 2017Buprenorphine Hydrochloride; Naloxone Hydrochloridebuprenorphine hydrochloride · Film

FDA 2017Tapentadol HydrochlorideTablet

FDA 2017Vantrela ERhydrocodone bitartrate · Tablet, extended release

FDA 2016Probuphinebuprenorphine hydrochloride · Implant

FDA 2016Xtampza ERoxycodone · Capsule, extended release